4.7 Article

Efficacy of Prolonged-Release Melatonin 2 mg (PRM 2 mg) Prescribed for Insomnia in Hospitalized Patients for COVID-19: A Retrospective Observational Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Critical Care Medicine

Delirium Assessment in Critically Ill Older Adults Considerations During the COVID-19 Pandemic

Maria C. Duggan et al.

Summary: During the COVID-19 pandemic, early recognition of delirium is crucial in managing critically ill older adults to prevent poor outcomes associated with delirium. Despite limitations in the healthcare system and challenging clinical circumstances, delirium screening and management remain an evidence-based cornerstone of critical care.

CRITICAL CARE CLINICS (2021)

Article Peripheral Vascular Disease

Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA)

Rita Del Pinto et al.

Summary: Hypertension is a major risk factor for fatal/nonfatal cardiovascular diseases, and sleep disorders can exacerbate this risk by inducing neurohormonal alterations and metabolic impairment. Evidence suggests that sleep disturbances are associated with resistant hypertension and impaired circadian blood pressure variations. The document by the Italian Society of Hypertension provides updated evidence and possible management strategies for addressing the link between sleep disorders and hypertension.

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2021)

Review Immunology

Can melatonin reduce the severity of COVID-19 pandemic?

Alex Shneider et al.

INTERNATIONAL REVIEWS OF IMMUNOLOGY (2020)

Review Virology

Melatonin: Roles in influenza, Covid-19, and other viral infections

George Anderson et al.

REVIEWS IN MEDICAL VIROLOGY (2020)

Letter Clinical Neurology

Delirium, sleep, COVID-19 and melatonin

Viroj Wiwanitkit

SLEEP MEDICINE (2020)

Review Medicine, General & Internal

Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19

Russel J. Reiter et al.

FRONTIERS IN MEDICINE (2020)

Review Medicine, Research & Experimental

COVID-19: Melatonin as a potential adjuvant treatment

Rui Zhang et al.

LIFE SCIENCES (2020)

Article Pharmacology & Pharmacy

Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19

Mohamed A. El-Missiry et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Review Medicine, General & Internal

Melatonin, aging, and COVID-19: Could melatonin be beneficial for COVID-19 treatment in the elderly?

Guler Ozturk et al.

TURKISH JOURNAL OF MEDICAL SCIENCES (2020)

Review Medicine, Research & Experimental

Can Melatonin Be a Potential Silver Bullet in Treating COVID-19 Patients?

Daniel P. Cardinali et al.

DISEASES (2020)

Article Pharmacology & Pharmacy

New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation

Nava Zisapel

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Review Clinical Neurology

Insomnia in the Elderly: A Review

Dhaval Patel et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2018)

Article Clinical Neurology

Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content

Lauren A. E. Erland et al.

JOURNAL OF CLINICAL SLEEP MEDICINE (2017)

Article Chemistry, Applied

Quality control and determination of melatonin in food supplements

Ana B. Cerezo et al.

JOURNAL OF FOOD COMPOSITION AND ANALYSIS (2016)

Article Clinical Neurology

Effects of prolonged-release melatonin and zolpidem on postural stability in older adults

Sarah Otmani et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)

Article Health Care Sciences & Services

Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal

Patrick Lemoine et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2011)

Article Pharmacology & Pharmacy

The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia

Remy Luthringer et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)

Article Medicine, General & Internal

Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of age sleep and next-day alertness outcomes

Alan G. Wade et al.

CURRENT MEDICAL RESEARCH AND OPINION (2007)